PRRT2 and Parkinson disease: On the other hand, Ferrostatin-1 derivatives and PKC inhibitors can also alleviate the progression of ferroptosis in PD 96, but the mechanism of the related nervous system is not clear at present, further research will be the basis for the development of PD and offers more possibilities for its clinical treatment.